Nevertheless, there are only few examples of small-molecule conjugates of ASGP-R selective ligand equipped by a therapeutic agent for the treatment of hepatocellular carcinoma (HCC).
The presence of the ASGP-R on the surface of DNA synthesizing cancer cells was also investigated after in vitro bromodeoxyuridine (BrdU) labelling of HCC samples by immunohistochemical visualization of both the ASGP-R and incorporated BrdU on the same section.
The asialoglycoprotein (ASGP) receptor isolated from human liver and from the human hepatoma cell line HepG2 migrates on NaDodSO4 gel electrophoresis as a single species of 45,000 daltons.